Both integrin‐FAK axis and MYC oncogene have been implicated in the regulation of pro‐metastatic traits of CRC such as cell motility, EMT, and tumor microenvironments [13, 16, 24, 33, 34]. The gene discussed is PTK2; the disease is neoplasm.